1. Introduction {#s0005}
===============

Smoking history is used to determine a patient's eligibility for lung cancer screening (LCS) with low-dose computed tomography (LDCT) ([@b0005], [@b0010]). The Centers for Medicare & Medicaid Services (CMS) and most insurers endorse a 30 pack-year smoking history threshold when determining eligibility for screening with low-dose CT. However, the National Comprehensive Cancer Network (NCCN) endorses a less conservative, 20 pack-year smoking history threshold when one additional risk factor is present ([@b0015]). To calculate pack-year smoking history, smokers are asked to report on the average number of cigarettes they smoked each day multiplied by the total number of years they have smoked. One pack-year is equivalent to smoking an average of 20 cigarettes (one pack) every day for one year.

Recall of smoking history has been used widely in research and epidemiological studies; however, self-reported smoking history is subject to recall bias that has the potential to impact eligibility for LCS. Observational studies have found that retrospective recall of smoking history is reliable ([@b0020], [@b0025]); however, no known studies have evaluated the reliability of pack-year smoking history among individuals who may be eligible for lung cancer screening based on their age. Here we examine the reliability of smokers' self-reported tobacco use and how differences in recall using both the 30 pack-year and 20 pack-year smoking history criteria may impact eligibility for LCS.

2. Materials and methods {#s0010}
========================

This study used a repeated-measures design to estimate the test-retest reliability of self-reported smoking history. Data were collected between December 2014 and September 2015. Participants were current or former smokers, ages 55--77 years, recruited from a tobacco treatment program (592 invited), a LCS program (88 invited), and advertisements in the local community (86 responded). To obtain daily and nondaily smokers, the duration and amount of cigarette use was not considered in determining eligibility; however, eligible participants had to have smoked at least 100 cigarettes in their lifetime. Of 766 initially invited to participate, 166 responded, of which 135 were eligible and agreed to participate. Baseline surveys were completed by 120 participants, with 102 providing complete data. Participants were mailed questionnaires (at baseline and one month after baseline) requesting demographic information and smoking history.

Participants responded to questions regarding their smoking history and habits. These questions follow the criteria for enrollment in the National Lung Screening Trial ([@b0030]), and are consistent with screening guidelines from the United States Preventive Services Task Force ([@b0005]) and coverage of screening by CMS ([@b0010]). The questions given to participants are shown in [Table 1](#t0005){ref-type="table"}.Table 1Questions asked to smokers and non-smokers regarding smoking history.1) "Have you smoked at least 100 cigarettes in your entire lifetime?"•If participant answers, "yes" to question 1.2) "How many years have/did you smoke?"3) "On average, how many cigarettes do/did you smoke per day?"4) "Do you currently smoke?"•If participant answers, "no" to question 4.5) "How many years ago did you quit smoking?"

Total pack-year exposure to cigarettes was calculated as average number of packs smoked per day × number of years smoked. Scatterplots were used to display the baseline and one-month follow-up smoking history reports for pack-years. The Kappa coefficient was used to assess agreement of the categorical pack-year smoking history reports (less than 30 pack-years, versus 30 or greater, and less than 20 pack-years, versus 20 of greater) at the two time periods. Agreement was also assessed separately for current and former smokers. Test-retest reliability of the smoking history data was estimated with intraclass correlation coefficients (ICCs) using a two-factor mixed effects model and type consistency ([@b0035]).

The research protocol was registered (ClinicalTrials.gov ID: NCT02282969) and approved for use of human subjects by the Institutional Review Board at The University of Texas MD Anderson Cancer Center.

3. Results {#s0015}
==========

Mean age of the 102 participants was 63.6 years, with roughly 10% over the age of 70 years. Twenty-four (23.5%) individuals were African American, while 72 (70.6%) identified as White. Fifty-five (53.9%) participants were female, and 19 (18.6%) had a high school degree or less. Half of the participants (n = 51) were current smokers and half were former smokers.

At the baseline and one-month follow-up assessment, 62 (60.8%) participants, versus 64 (62.7%) participants, respectively, reported at least a 30 pack-year smoking history (Kappa = 0.83, p \< .001). High test-retest reliability was observed for pack-year estimates, with an ICC greater than 0.90 (see [Fig. 1](#f0005){ref-type="fig"}). Based on the 30 pack-year threshold, 35 (34.3%) participants did not meet eligibility at either assessment period, 59 (57.8%) were eligible at both assessments, and 8 (7.8%) were eligible at only one assessment period. Among current smokers, 7 of 51 (13.7%) were eligible at one assessment period but not the other (Kappa = 0.73, p \< .001). For former smokers, only 1 of 51 (2.0%) was eligible at only one assessment period (Kappa = 0.95, p \< .001).Fig. 1Scatterplot of Pack-Year Smoking History from Baseline and 1-month Reports (n = 102). \*ICC = intraclass correlation coefficient. Solid line represents 30 pack-year threshold. Dashed line represents 20 pack-year threshold. Cases in the upper right quadrant exceed the respective 30/20 pack-year threshold at baseline and 1 month periods; cases in lower left quadrant reported less than the respective 30/20 pack-years at both time periods; other cases were inconsistent across time periods.

At the baseline and one-month follow-up assessment, 77 (75.5%) participants, versus 73 (71.6%) participants, respectively, reported at least a 20 pack-year smoking history (Kappa = 0.70, p \< .001). Using the 20 pack-year threshold, 21 (20.6%) participants did not meet eligibility at either assessment period, 69 (67.6%) were eligible at both assessments, and 12 (11.8%) were eligible at only one assessment period. Among current smokers, 8 of 51 (15.7%) were eligible at only one assessment period but not the other (Kappa = 0.64, p \< .001). For former smokers, 4 of 51 (7.8%) was eligible at only one assessment period (Kappa = 0.77, p \< .001).

4. Discussion {#s0020}
=============

Smokers' self-reported tobacco use history appears highly reliable over short periods of time, when standard questions about smoking history are used. Nevertheless, there is some inconsistent reporting which appears more pronounced among current compared to former smokers (up to 16% of current smokers were inconsistent in reporting their smoking history using the 20 pack-year threshold). Prior survey-based studies have also found that self-reported smoking history is reliable ([@b0025]). These findings are encouraging because pack-year smoking history as a measure of smoking intensity has its roots in epidemiologic research and is now being used in clinical settings as an eligibility criterion for LCS.

In clinical practice the medical record is likely the source for determining smoking history. Numerous studies utilizing chart audits and electronic health records show less than half of patient encounters include documentation of tobacco history ([@b0040], [@b0045], [@b0050]). Further studies comparing self-reported pack years determined during a shared decision making (SDM) conversation compared to information in the electronic medical record show high levels of discordance between the two, highlighting the importance of the SDM conversation itself for determining LCS eligibility ([@b0055]). Unfortunately, these conversations are happening infrequently ([@b0060]) and the opportunity of explore or increase precision of tobacco use history is often lost.

The study limitations include inability to determine systematic over and under-reporting of smoking status ([@b0065]). Accuracy of tobacco use in the absence of an objective measure cannot be determined. Additionally, it was not possible to explore reliability among different subgroups of current and former smokers because of the sample size.

We recommend that clinicians carefully assess smoking history, probe patients' recall of duration and quantity of smoking, and collect tobacco use information at every encounter ([@b0070], [@b0050]). Clinical judgment should play a key role in deciding which patients are considered appropriate screening candidates. Most importantly, clinicians should not lose sight of the primary importance of encouraging smoking cessation and abstinence in lowering the risk of lung cancer.
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